Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals

Area of Science:

• Neuroscience
• Pharmacology
• Cognitive Science

Background:

• Previous research with mixed beta-blockers showed minimal impact on prefrontal cortex cognition.
• Emerging evidence suggests beta1 adrenoceptor stimulation impairs working memory in rodents and primates.

Purpose of the Study:

• To investigate the hypothesis that activating beta2 adrenoceptors could enhance working memory performance.
• To examine the effects of the beta2 agonist clenbuterol on spatial working memory.

Main Methods:

• Clenbuterol was administered directly into the prefrontal cortex of rats and systemically to monkeys.
• Performance on spatial working memory tasks was assessed in young and aged animals.
• The beta2 antagonist ICI 118,551 was used to confirm the specificity of clenbuterol's actions.

Main Results:

• Clenbuterol administration improved spatial working memory performance in a significant portion of poorly performing young and aged rats and monkeys.
• The pro-cognitive effects of clenbuterol were confirmed through blockade with ICI 118,551.
• The drug's efficacy was dependent on the animal's baseline cognitive status, benefiting only a subset with working memory deficits.

Conclusions:

• Activation of beta2 adrenoceptors, specifically within the prefrontal cortex, can enhance spatial working memory.
• Targeting beta2 adrenoceptors represents a potential therapeutic strategy for cognitive impairment, particularly in individuals with pre-existing working memory deficits.